Symposia: Scientific Workshop on Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure
	
	
	Program: Scientific Workshops
	
	
	Friday, December 8, 2023: 3:37 PM-4:18 PM
	Room 29 
		(San Diego Convention Center)
	
	
	
	
	   
			
		Moderators:
			
				
				
					
						
						
						
							Christopher N. Hahn, PhD, Molecular Pathology Research Laboratory, Centre for Cancer Biology
											
					
					
				
					
						 and 
						
						
							Grace Christou, MD, MSc, FRCPC, The Ottawa Hospital
											
					
					
				
			
 
			
			Disclosures:
			
			
				
			
				
			
			Christou: Jazz Pharma: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees. 
			 
		Germline predisposition that intersects with lymphoid malignancies, solid tumors, and DNA repair pathways.
Predisposition to lymphoid malignancies is probably less well characterised than to myeloid malignancies. This session will address a growing understanding of hereditary predisposition to lymphoid malignancies. 
Dr. Armanios – Inherited hematological malignancies in Long Telomere Syndrome.
Dr. Lesmana – Germline mutations in POT1 in pediatric lymphoma.
Dr. Reed – Lymphoid malignancy in Shwachman-Diamond syndrome.
Dr. Sharma – Lymphoid malignancies in Ataxia telangiectasia.
Dr. McReynolds – Fanconi anemia heterozygotes do not exhibit increased cancer risk.
		
		
	
	
	
	
	
	
	 
	
	 denotes an abstract that is clinically relevant.
 denotes an abstract that is clinically relevant. denotes that this is a recommended PHD Trainee Session.
 denotes that this is a recommended PHD Trainee Session. denotes that this is a ticketed session.
 denotes that this is a ticketed session.